US5089655A - Individual α-form particle crystals of tetrakis[3-(3,5-di-t-butyl-4-hydroxyphenyl)propionyloxymethyl]methane and process for its production - Google Patents

Individual α-form particle crystals of tetrakis[3-(3,5-di-t-butyl-4-hydroxyphenyl)propionyloxymethyl]methane and process for its production Download PDF

Info

Publication number
US5089655A
US5089655A US07/403,492 US40349289A US5089655A US 5089655 A US5089655 A US 5089655A US 40349289 A US40349289 A US 40349289A US 5089655 A US5089655 A US 5089655A
Authority
US
United States
Prior art keywords
crystal
crystals
compound
hydroxyphenyl
butyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
US07/403,492
Inventor
Takanori Miura
Masanori Kohara
Kunihide Oka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
API Corp
Original Assignee
Welfide Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26398380&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US5089655(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from JP22399788A external-priority patent/JPH07116104B2/en
Priority claimed from JP1057353A external-priority patent/JPH07116105B2/en
Application filed by Welfide Corp filed Critical Welfide Corp
Assigned to YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. reassignment YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. ASSIGNMENT OF ASSIGNORS INTEREST. Assignors: KOHARA, MASANORI, MIURA, TAKANORI, OKA, KUNIHIDE
Application granted granted Critical
Publication of US5089655A publication Critical patent/US5089655A/en
Assigned to WELFIDE CORPORATION reassignment WELFIDE CORPORATION CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD.
Assigned to YOSHITOMI FINE CHEMICALS, LIMITED reassignment YOSHITOMI FINE CHEMICALS, LIMITED ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: WELFIDE CORPORATION
Assigned to API CORPORATION reassignment API CORPORATION CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: YOSHITOMI FINE CHEMICALS, LTD.
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/612Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/48Separation; Purification; Stabilisation; Use of additives
    • C07C67/52Separation; Purification; Stabilisation; Use of additives by change in the physical state, e.g. crystallisation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/732Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids

Definitions

  • This invention relates to novel individual particle crystals of tetrakis[3-(3,5-di-t-butyl-4-hydroxyphenyl)propionyloxymethyl]methane (hereinafter sometimes referred to as Compound-A) in an ⁇ -crystal form which is useful as an antioxidant for polyolefins and the like.
  • Compound-A tetrakis[3-(3,5-di-t-butyl-4-hydroxyphenyl)propionyloxymethyl]methane
  • ⁇ -crystal form which is useful as an antioxidant for polyolefins and the like.
  • individual particle crystals of Compound-A having ⁇ -crystal form comprising crystals in substantially cubic or rectangular parallelepipedal shape or aggregates thereof.
  • Compound-A has a property crystallographically called multiple forms, which means that it has various stable or semi-stable crystal forms representable by the same chemical structure.
  • multiple forms which means that it has various stable or semi-stable crystal forms representable by the same chemical structure.
  • several crystal forms defined as ⁇ -form, ⁇ -form, ⁇ -form, ⁇ -form and the like.
  • the above-mentioned marketed products are in the ⁇ -crystal forms.
  • the objective crystal forms can be obtained.
  • the crystals in the ⁇ -form which belongs to the stable crystal forms can be obtained by recrystallization from a solvent such as n-heptane, n-hexane or methanol as disclosed in the offical gazette publications of Japanese Patent Applications Publication (Kokoku) Nos. 18617/1967 and 19083/1967, Japanese Patent Application Laid-open (Kokai) No. 156645/1985 and so on.
  • a solvent such as n-heptane, n-hexane or methanol
  • the heretofore proposed methods for improvement relate to preparing Compound-A in the ⁇ -form and in the individual particle ⁇ -form, both of which are unstable crystal forms, avoiding the ⁇ -form which is inferior in purity and powder property, for the purpose of obtaining Compound-A having superior powder property.
  • These methods cannot be looked upon as economical in that the number of steps is increased and a large amount of impurity is allowed to exist.
  • the object of this invention is to provide Compound-A having high purity and excellent powder property in an ⁇ -crystal form which belongs to stable crystal forms, that is, ⁇ -form crystals of Compound-A in individual particle forms, comprising crystals in substantially cubic or rectangular parallelepipedal shape or aggregates thereof.
  • Another object of this invention is to provide a process for the production of such individual ⁇ -form crystals of Compound-A as mentioned hereinbefore.
  • FIG. 1 shows the X-ray diffraction spectrum of the compound of the present invention as obtained in accordance with Example 1;
  • FIG. 2 shows the X-ray diffraction spectrum of the marketed product as used in Example 1;
  • FIG. 3 shows the X-ray diffraction spectrum of the compound of the present invention as obtained in accordance with Example 3;
  • FIG. 4 shows the X-ray diffraction spectrum of the compound as obtained in accordance with comparative Example 1;
  • FIG. 5 shows the microscopic photograph of the ⁇ -form crystals in individual particle form as obtained in accordance with the present invention
  • FIG. 6 shows the microscopic photograph of the ⁇ -form crystals as obtained by the hitherto-known method
  • FIG. 7 shows the microscopic photograph of the marketed product
  • FIG. 8 shows the hopper as used for the measurement of the falling velocity (1 indicates the cylinder section, 2 indicates the conic section and 3 indicates the outlet of the sample).
  • the present inventors have conducted intensive studies on the crystal forms of Compound-A, particularly the ⁇ -forms to find an ⁇ -form Compound-A which has good powder property and novel particle form different from that of the hitherto-known ⁇ -form, which culminated in the completion of the present invention.
  • This invention relates to tetrakis[3-(3,5-di-t-butyl-4-hydroxyphenyl)propionyloxymethyl]methane in individual ⁇ -form particle crystal forms, comprising individual ⁇ -form particle crystals in substantially cubic or rectangular parallelepipedal shape and aggregates thereof, which can be obtained by recrystallization from an aliphatic saturated hydrocarbon having 8-10 carbon atoms alone or a mixture thereof with a small amount of methanol as the recrystallization solvent of tetrakis[3-(3,5-di-t-butyl-4-hydroxyphenyl)propionylmethyl]methane which can be prepared by subjecting methyl 3-(3,5-di-t-butyl-4-hydroxyphenyl)propionate and pentaerythritol to ester interchange reaction, or the marketed product thereof.
  • the aliphatic saturated hydrocarbon having 8-10 carbon atoms to be used as the solvent mention is made of Iso-Par (Exxon Chemical's commercial product name), Shellsol (Shell Chemical's commercial product name), IP Solvent (Idemitsu Chemical's commercial product name) and so on.
  • methanol When methanol is added, it is added preferably in a proportion of 1 to 4% by weight relative to the amount of said solvent.
  • the content of Compound-A before crystallization is about 85 to about 98%.
  • the crystallization temperature is in the range from 70° C. to 20° C.
  • the ⁇ -form Compound-A in individual particle forms of the present invention comprises the crystal particles having a crystal particle diameter of not more than 0.1 mm in a proportion of not more than 5% by weight, and more preferably, it has the following homogenous crystal particle size distribution:
  • the crystal particles of a crystal particle diameter of more than 1 mm share no more than 1% by weight;
  • the crystal particles of a crystal particle diameter ranging from 0.1 to 1 mm share no less than 94% by weight; and the crystal particles of a crystal particle diameter below 0.1 mm share no more than 5% by weight.
  • the Compound-A obtainable according to the present invention is deemed to have a crystal structure in the ⁇ -form. As shown in the microscopic photograph in FIG. 5, it comprises crystal particles in substantially cubic or rectangular parallelepipedal shape and aggregates thereof, and it comprises only a little amount of fine powders. From the foregoing, the Compound-A of the present invention has a particle form definitely distinguishable from the ⁇ -form crystals obtained by the hitherto known method as shown in the microscopic photograph in FIG. 6.
  • the ⁇ -form crystals of Compound-A obtained in accordance with the present invention are in substantially individual particle forms, they bear characteristics of excellent powder property in the following respects: they can be easily purified by recrystallization; the particle size distribution is homogeneous; the diversity of the particle size distribution is narrow; the bulk density is high; they are not so easily pulverized in drying and transportation and the like. Therefore, they are extremely advantageous in that working efficiency and working environment is improved.
  • the Compound-A in the ⁇ -form of the present invention has high purity and excellent powder property which the hitherto-known ⁇ -form fails to have, and is easily produced.
  • the mixture was gradually cooled under stirring, and at 70° C., a small quantity of crystals in the ⁇ -form was added as the seed crystals. When the mixture had been stirred at 60°-50° C. for 4 hours, most of the crystals deposited. Further, the mixture was cooled to 30° C. for the completion of crystallization. The resulting slurry was filtered by sunction-filtration and dried to give 146 g of white crystals of high fluidity. The melting point of 122°-124° C. and X-ray diffraction spectrum as shown in FIG. 1 confirmed that the crystals were in the ⁇ -form.
  • Example 2 By conducting the same procedure as that in Example 1 except that 3.7 g of methanol was additionally added for dissolution, 145 g of white crystals having excellent fluidity was obtained. The melting point of 122°-124° C. and the X-ray diffraction spectrum confirmed that the crystals were in the ⁇ -form.
  • reaction mixture was 483 g after the pressure was enhanced to the atmospheric pressure, and the reaction mixture was found to contain the objective compound in an amount of 89% from the result of the analysis by HPLC.
  • Example 3 Using 150 g of the reaction product as obtained in Example 3 and 170 g of methanol as used in Example 1 of Japanese Patent Application Kokai No. 156645/1985 instead of Iso-Par E used in Example 3, after heating to 60° C. to obtain a homogeneous solution, crystallization was conducted in the same manner as that described in Example 3. The obtained crystals were washed with 100 ml of cool methanol and dried to give 120 g of white powders. The melting point (122°-124° C.) and the X-ray diffraction spectrum as shown in FIG. 4 confirmed that these crystals were in the ⁇ -form.
  • the characteristics of the crystals of Examples 1-3, Comparative Examples 1-3 and the marketed product are tabulated in Table 1.
  • the bulk density and angle of repose were measured a powder tester (manufactured by Hosokawa Micron).
  • the falling velocity was obtained by measuring the falling velocity from the stainless steel hopper as shown in FIG. 8, (wherein the diameter of the cylinder section 1 is 83 mm, the diameter of outlet 3 is 8 mm, and the height of the conic section 2 is 65 mm) the less the value is, the higher the fluidity.
  • the marketed product was one manufactured by Ciba-Geigy Corporation.
  • the mechanical strength of the crystal particles of Compound-A obtained in Example 2 was tested by shaking-stirring method.
  • the sample (100 g) was put in a 1000 ml-flask, which was shaken for 7 hours, and the results of the particle size distribution before and after the test are shown in Table 2. From the fact that there is little difference between the particle size distribution before and after the test, it is shown that the mechanical strength of the crystal particles is high.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Novel individual α-form particle crystals of tetrakis[3-(3,5,-di-t-butyl-4-hydroxyphenyl)propionyloxymethyl]methane and process for its production are disclosed.

Description

BACKGROUND OF THE INVENTION
This invention relates to novel individual particle crystals of tetrakis[3-(3,5-di-t-butyl-4-hydroxyphenyl)propionyloxymethyl]methane (hereinafter sometimes referred to as Compound-A) in an α-crystal form which is useful as an antioxidant for polyolefins and the like. In further detail, it relates to individual particle crystals of Compound-A having α-crystal form, comprising crystals in substantially cubic or rectangular parallelepipedal shape or aggregates thereof.
The products of Compound-A marketed presently have critical deflects in workability, measurability and environmental hygiene since they are inferior in powder-properties, for example, in that they are in the fine powder form, of low bulk density and of inferior fluidity and easily scatter and drift in handling. Therefore, improvement is desired.
Compound-A has a property crystallographically called multiple forms, which means that it has various stable or semi-stable crystal forms representable by the same chemical structure. Heretofore, there have been known several crystal forms defined as α-form, β-form, γ-form, δ-form and the like. The above-mentioned marketed products are in the β-crystal forms. There is close relationship between the respective crystal forms and the purity and powder property (micromeritical property) of Compound-A. By a variety of methods, the objective crystal forms can be obtained.
Hitherto, there have been presented proposals for improving the defects of the marketed products by preparing Compound-A in particular crystal forms or by obtaining Compound-A by combination of a particular crystal form with a particular particle form. For example, (1) in the official gazette publications of Japanese Patent Applications Publication (Kokoku) Nos. 13018/1985 and 13017/1985, the powder property, which is a defect of α-crystal and the marketed β-crystal, is improved by obtaining Compound-A in the δ-form which is a semi-stable crystal form and (2) in the official gazette publication of Japanese Patent Application Laid-open (Kokai) No. 258343/1987, are improved the defects of the marketed products by obtaining Compound-A in individual particle crystal forms by recrystallizing under special conditions, though in the same semi-stable β-form as the form of the marketed products.
On the other hand, the crystals in the α-form which belongs to the stable crystal forms, can be obtained by recrystallization from a solvent such as n-heptane, n-hexane or methanol as disclosed in the offical gazette publications of Japanese Patent Applications Publication (Kokoku) Nos. 18617/1967 and 19083/1967, Japanese Patent Application Laid-open (Kokai) No. 156645/1985 and so on. However, the case is that these crystals are the most inferior both in purity and in powder property, and therefore are less valuable products.
As mentioned above, the heretofore proposed methods for improvement relate to preparing Compound-A in the δ-form and in the individual particle β-form, both of which are unstable crystal forms, avoiding the α-form which is inferior in purity and powder property, for the purpose of obtaining Compound-A having superior powder property. These methods, however, cannot be looked upon as economical in that the number of steps is increased and a large amount of impurity is allowed to exist.
That is, according to the methods of Japanese Patent Applications Publication (Kokoku) Nos. 13017/1985 and 13018/1985, in the ester interchange reaction, it is necessary to add a dicarboxylic acid ester of the formula (1) ##STR1## wherein R1 and R3 respectively stand for an alkyl group having 1-6 carbon atoms and it is also necessary to isolate the molecular adduct of Compound-A with isopropanol, which results in the increase in the number of the steps. Thus, the methods are not economical. In the method of Japanese Patent Application Kokai No. 258343 1987, it is necessary to allow methyl or ethyl 3-(3,5-di-t-butyl-4-hydroxyphenyl)propionate, which is a starting compound, and the tris-substituted compound of the formula (2) ##STR2## which is an intermediate compound resulting from incomplete reaction, to be contained in a large amount before purification by recrystallization (as described in the specification, when the content of the objective Compound-A is too high at the completion of the reaction, it is required to add the starting compound or the tris-substituted compound (2) and purposely mix them therewith). Thus, the obtained products tend to have reduced purity and also the yield of the recrystallization is lowered, and the method is not an economical one.
SUMMARY OF THE INVENTION
The object of this invention is to provide Compound-A having high purity and excellent powder property in an α-crystal form which belongs to stable crystal forms, that is, α-form crystals of Compound-A in individual particle forms, comprising crystals in substantially cubic or rectangular parallelepipedal shape or aggregates thereof.
Another object of this invention is to provide a process for the production of such individual α-form crystals of Compound-A as mentioned hereinbefore.
BRIEF DESCRIPTION OF THE DRAWING
FIG. 1 shows the X-ray diffraction spectrum of the compound of the present invention as obtained in accordance with Example 1;
FIG. 2 shows the X-ray diffraction spectrum of the marketed product as used in Example 1;
FIG. 3 shows the X-ray diffraction spectrum of the compound of the present invention as obtained in accordance with Example 3;
FIG. 4 shows the X-ray diffraction spectrum of the compound as obtained in accordance with comparative Example 1;
FIG. 5 shows the microscopic photograph of the α-form crystals in individual particle form as obtained in accordance with the present invention;
FIG. 6 shows the microscopic photograph of the α-form crystals as obtained by the hitherto-known method;
FIG. 7 shows the microscopic photograph of the marketed product; and
FIG. 8 shows the hopper as used for the measurement of the falling velocity (1 indicates the cylinder section, 2 indicates the conic section and 3 indicates the outlet of the sample).
DETAILED DESCRIPTION
The present inventors have conducted intensive studies on the crystal forms of Compound-A, particularly the α-forms to find an α-form Compound-A which has good powder property and novel particle form different from that of the hitherto-known α-form, which culminated in the completion of the present invention.
This invention relates to tetrakis[3-(3,5-di-t-butyl-4-hydroxyphenyl)propionyloxymethyl]methane in individual α-form particle crystal forms, comprising individual α-form particle crystals in substantially cubic or rectangular parallelepipedal shape and aggregates thereof, which can be obtained by recrystallization from an aliphatic saturated hydrocarbon having 8-10 carbon atoms alone or a mixture thereof with a small amount of methanol as the recrystallization solvent of tetrakis[3-(3,5-di-t-butyl-4-hydroxyphenyl)propionylmethyl]methane which can be prepared by subjecting methyl 3-(3,5-di-t-butyl-4-hydroxyphenyl)propionate and pentaerythritol to ester interchange reaction, or the marketed product thereof.
As specific examples of the aliphatic saturated hydrocarbon having 8-10 carbon atoms to be used as the solvent, mention is made of Iso-Par (Exxon Chemical's commercial product name), Shellsol (Shell Chemical's commercial product name), IP Solvent (Idemitsu Chemical's commercial product name) and so on. When methanol is added, it is added preferably in a proportion of 1 to 4% by weight relative to the amount of said solvent. The content of Compound-A before crystallization is about 85 to about 98%. The crystallization temperature is in the range from 70° C. to 20° C.
The α-form Compound-A in individual particle forms of the present invention comprises the crystal particles having a crystal particle diameter of not more than 0.1 mm in a proportion of not more than 5% by weight, and more preferably, it has the following homogenous crystal particle size distribution:
the crystal particles of a crystal particle diameter of more than 1 mm share no more than 1% by weight;
the crystal particles of a crystal particle diameter ranging from 0.1 to 1 mm share no less than 94% by weight; and the crystal particles of a crystal particle diameter below 0.1 mm share no more than 5% by weight.
FUNCTION
From the X-ray (Cu - Kα) diffraction spectrum as shown in FIG. 1 and the melting point of 122°-124° C., the Compound-A obtainable according to the present invention is deemed to have a crystal structure in the α-form. As shown in the microscopic photograph in FIG. 5, it comprises crystal particles in substantially cubic or rectangular parallelepipedal shape and aggregates thereof, and it comprises only a little amount of fine powders. From the foregoing, the Compound-A of the present invention has a particle form definitely distinguishable from the α-form crystals obtained by the hitherto known method as shown in the microscopic photograph in FIG. 6.
Besides, since the α-form crystals of Compound-A obtained in accordance with the present invention, unlike the hitherto-known crystals in the α-form, are in substantially individual particle forms, they bear characteristics of excellent powder property in the following respects: they can be easily purified by recrystallization; the particle size distribution is homogeneous; the diversity of the particle size distribution is narrow; the bulk density is high; they are not so easily pulverized in drying and transportation and the like. Therefore, they are extremely advantageous in that working efficiency and working environment is improved. Thus, the Compound-A in the α-form of the present invention has high purity and excellent powder property which the hitherto-known α-form fails to have, and is easily produced.
Below, the present invention is specifically described by examples, but the present invention is not limited thereto.
EXAMPLE 1
In a 500 ml-four-mouthed flask were put 150 g of marketed tetrakis[3-(3,5-di-t-butyl-4-hydroxyphenyl)propionyloxymethyl]methane (This product is in the form of fine powders as shown in the microscopic photograph in FIG. 7, and it has m.p. of 112°-114° C. and the β-form crystal structure as shown in the X-ray diffraction spectrum in FIG. 2.) and 180 g of Iso-Par E (a solvent of an aliphatic saturated hydrocarbon of 8-10 carbon atoms marketed by Exxon Chemical , and the mixture was heated to 95° C. to be completely dissolved. The mixture was gradually cooled under stirring, and at 70° C., a small quantity of crystals in the α-form was added as the seed crystals. When the mixture had been stirred at 60°-50° C. for 4 hours, most of the crystals deposited. Further, the mixture was cooled to 30° C. for the completion of crystallization. The resulting slurry was filtered by sunction-filtration and dried to give 146 g of white crystals of high fluidity. The melting point of 122°-124° C. and X-ray diffraction spectrum as shown in FIG. 1 confirmed that the crystals were in the α-form.
The characteristics of the obtained crystals as compared with those of the crystals in the α-form of the marketed product and those of the crystals obtained by the conventional method are tabulated in Table 1.
EXAMPLE 2
By conducting the same procedure as that in Example 1 except that 3.7 g of methanol was additionally added for dissolution, 145 g of white crystals having excellent fluidity was obtained. The melting point of 122°-124° C. and the X-ray diffraction spectrum confirmed that the crystals were in the α-form.
EXAMPLE 3
A 1 l-four-mouthed flask equipped with a stirrer, a reflux-condenser, a thermometer and pressure reduction-adjusting valve was charged with 479.5 g of methyl 3-(3,5-di-t-butyl- 4-hydroxyphenyl)propionate, 54.5 g of pentaerythritol and 0.25 g of dibutyltin oxide, and the mixture was reacted at 195° C. under atmospheric pressure for 2 hours and methanol resulting as by-product was distilled off. The mixture was reacted at 195° C. under reduced pressure of 40 mmHg for 2 hours and further at 195° C. under reduced pressure of 2-5 mmHg for 12 hours, and methanol resulting as the by-product was distilled off for the completion of the reaction. The weight of the reaction mixture was 483 g after the pressure was enhanced to the atmospheric pressure, and the reaction mixture was found to contain the objective compound in an amount of 89% from the result of the analysis by HPLC.
In a 500 ml-four-mouthed flask were put 150 g of the reaction mixture, 170 g of Iso-Par E and 6.2 g of methanol, and the mixture was heated to 85° C. to give a homogeneous solution. Thereafter, the mixture was gradually cooled and at 55° C., a small amount of seed crystals in the α-form was added. The mixture was allowed to be crystallized at 50°-45° C. for 8 hours, and then cooled to 25° C. for the completion of the crystallization. The crystals were collected by filtration, washed with 100 g of cooled Iso-Par E and dried to give 126 g of white crystals of high fluidity. The melting point of 122°-124° C. and the X-ray diffraction spectrum as shown in FIG. 3 confirmed that these crystals were in the α-form.
COMPARATIVE EXAMPLE 1
Using 150 g of the reaction product as obtained in Example 3 and 170 g of methanol as used in Example 1 of Japanese Patent Application Kokai No. 156645/1985 instead of Iso-Par E used in Example 3, after heating to 60° C. to obtain a homogeneous solution, crystallization was conducted in the same manner as that described in Example 3. The obtained crystals were washed with 100 ml of cool methanol and dried to give 120 g of white powders. The melting point (122°-124° C.) and the X-ray diffraction spectrum as shown in FIG. 4 confirmed that these crystals were in the α-form.
COMPARATIVE EXAMPLE 2
By conducting the same procedure as in Comparative Example 1 using n-heptane which is used in Example 2 of Japanese Patent Application Publication (Kokoku) No. 18617/1967 instead of methanol in Comparative Example 1, 118 g of pale yellow powders was obtained. The melting point and X-ray diffraction spectrum confirmed that these powders were α-form crystals.
COMPARATIVE EXAMPLE 3
By conducting the same procedure as in Comparative Example 1 except that the crystallization temperature was changed to 40° C. and n-hexane as used in Example 1 of Japanese Patent Application Publication (Kokoku) No. 19083/1967 was used instead of methanol in Comparative Example 1, 125 g of pale yellow powders was obtained. The melting point and X-ray diffraction spectrum confirmed that these powders were α-form crystals.
TEST EXAMPLE 1
The characteristics of the crystals of Examples 1-3, Comparative Examples 1-3 and the marketed product are tabulated in Table 1. The bulk density and angle of repose were measured a powder tester (manufactured by Hosokawa Micron). The falling velocity was obtained by measuring the falling velocity from the stainless steel hopper as shown in FIG. 8, (wherein the diameter of the cylinder section 1 is 83 mm, the diameter of outlet 3 is 8 mm, and the height of the conic section 2 is 65 mm) the less the value is, the higher the fluidity. The marketed product was one manufactured by Ciba-Geigy Corporation.
                                  TABLE 1                                 
__________________________________________________________________________
                            Comparative                                   
                                   Comparative                            
                                          Comparative                     
                                                 Marketed                 
          Example 1                                                       
                Example 2                                                 
                      Example 3                                           
                            Example 1                                     
                                   Example 2                              
                                          Example 3                       
                                                 Product                  
__________________________________________________________________________
Recrystallization                                                         
          Iso-Par E                                                       
                Iso-Par E                                                 
                      Iso-Par E                                           
                            Methanol                                      
                                   n-heptane                              
                                          n-hexane                        
                                                 --                       
solvent         Methanol                                                  
                      Methanol                                            
Appearance                                                                
          White White White White  Pale-yellow                            
                                          Pale-yellow                     
                                                 White                    
          crystals                                                        
                crystals                                                  
                      crystals                                            
                            crystals                                      
                                   powder powder powder                   
HPLC purity (%)                                                           
          98.0  97.0  96.1  96.5   95.2   94.6   97.0                     
m.p. (°C.)                                                         
          122-124                                                         
                122-124                                                   
                      122-124                                             
                            122-125                                       
                                   118-122                                
                                          116-122                         
                                                 113-114                  
Crystal form                                                              
          α                                                         
                α                                                   
                      α                                             
                            α                                       
                                   α                                
                                          α                         
                                                 β                   
Bulk density (g/ml)                                                       
          0.54  0.55  0.46  0.28   0.30   0.33   0.35                     
Angle of repose (°)                                                
          40    40    46    48     51     51     50                       
Falling velocity                                                          
          11    12    13    95     185    200    210                      
(sec./100 ml)                                                             
Particle size                                                             
distribution (%)                                                          
>1 mm     0     0.2   0     4.3    0      0      0.1                      
1.0-0.50 mm                                                               
          0.2   0.2   1.6   4.4    5.4    6.8    0.1                      
0.50-0.25 mm                                                              
          61.9  6.4   1.2   18.1   15.6   18.2   14.1                     
0.25-0.10 mm                                                              
          37.8  90.1  93.1  69.7   45.3   45.7   53.7                     
<0.1 mm   0.1   3.1   3.8   2.9    32.7   29.3   32.0                     
__________________________________________________________________________
TEST EXAMPLE 2
The mechanical strength of the crystal particles of Compound-A obtained in Example 2 was tested by shaking-stirring method. The sample (100 g) was put in a 1000 ml-flask, which was shaken for 7 hours, and the results of the particle size distribution before and after the test are shown in Table 2. From the fact that there is little difference between the particle size distribution before and after the test, it is shown that the mechanical strength of the crystal particles is high.
              TABLE 2                                                     
______________________________________                                    
Particle size Before shaking                                              
                          After shaking                                   
______________________________________                                    
>1 mm         0.2%          0%                                            
1.0-0.5 mm    0.2%         2.2%                                           
0.5-0.25 mm   6.4%        11.5%                                           
0.25-0.10 mm  90.1%       81.6%                                           
<0.1 mm       3.1%         4.7%                                           
______________________________________                                    
While the present invention has been described by the foregoing specification including working examples and test examples, the embodiments described herein can be changed and modified in various manners within the scope and the spirit of this invention.

Claims (9)

We claim:
1. Tetrakis [3-(3,5-di-t-butyl-4-hydroxyphenyl)propionyloxymethyl]methane in individual particle crystal forms, comprising individual α-form crystals in substantially cubic or rectangular parallelepipedal shape and aggregates thereof.
2. A compound as claimed in claim 1, wherein the crystal particles having a crystal particle diameter of not more than 0.1 mm share no more than 5% by weight.
3. A compound as claimed in claim 1, wherein the crystal particle size distribution is as follows:
the crystal particles of a crystal particle diameter of more than 1 mm share no more than 1% by weight;
the crystal particles of a crystal particle diameter ranging from 0.1 to 1 mm share no less than 94% by weight;
and the crystal particles of a crystal particle diameter below 0.1 mm share no more than 5% by weight.
4. A compound as claimed in claim 1, wherein the crystals are pulverized.
5. A process for the production of tetrakis[-(3,5-di-t-butyl-4-hydroxyphenyl)propionyloxymethyl]methane in individual α-form particle crystal forms comprising crystals in substantially cubic or rectangular pallarelepipedal and aggregates thereof, which comprises crystallizing tetrakis[3-(3,5-di-t-butyl-4-hydroxyphenyl)propionyloxymethyl]-methane from an aliphatic saturated hydrocarbon having 8-10 carbon atoms or a mixture thereof with a small amount of methanol as the crystallization solvent.
6. A process as claimed in claim 5 wherein the crystallization solvent is a mixture containing 1-4% by weight of methanol relative to the amount of the aliphatic saturated hydrocarbon having 8-10 carbon atoms.
7. A process as claimed in claim 5 wherein the content of tetrakis[3-(3,5-di-t-butyl-4-hydroxyphenyl)propionyloxymethyl]methane prior to crystallization is 85-98%.
8. A process as claimed in claim 5 wherein the crystallization temperature is in the range from 70°-20° C.
9. A process as claimed in claim 5 wherein the crystallization solvent is an aliphatic saturated hydrocarbon having 8-10 carbon atoms or a mixture thereof with 1-4% by weight of methanol relative to the amount of the aliphatic saturated hydrocarbon.
US07/403,492 1988-09-07 1989-09-06 Individual α-form particle crystals of tetrakis[3-(3,5-di-t-butyl-4-hydroxyphenyl)propionyloxymethyl]methane and process for its production Expired - Fee Related US5089655A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP22399788A JPH07116104B2 (en) 1988-09-07 1988-09-07 Method for producing tetrakis [3- (3,5-di-t-butyl-4-hydroxyphenyl) propionyloxymethyl] methane having good powder properties
JP63-223997 1988-09-07
JP1-57353 1989-03-08
JP1057353A JPH07116105B2 (en) 1989-03-08 1989-03-08 Independent particle α-crystal tetrakis [3- (3,5-di-t-butyl-4-hydroxyphenyl) propionyloxymethyl] methane and method for producing the same

Publications (1)

Publication Number Publication Date
US5089655A true US5089655A (en) 1992-02-18

Family

ID=26398380

Family Applications (1)

Application Number Title Priority Date Filing Date
US07/403,492 Expired - Fee Related US5089655A (en) 1988-09-07 1989-09-06 Individual α-form particle crystals of tetrakis[3-(3,5-di-t-butyl-4-hydroxyphenyl)propionyloxymethyl]methane and process for its production

Country Status (4)

Country Link
US (1) US5089655A (en)
EP (1) EP0358157B1 (en)
KR (1) KR920000911B1 (en)
DE (1) DE68911436T2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH085844B2 (en) * 1989-06-08 1996-01-24 吉富製薬株式会社 ALPHA.-Crystal tetrakis [3- (3,5-di-t-butyl-4-hydroxyphenyl) propionyloxymethyl] methane having excellent fluidity and method for producing the same
JPH03284652A (en) * 1990-03-30 1991-12-16 Kokusai Kagaku Gijutsu Consultant Kk Granular tetrakis(3-(3,5-dibutyl-4-hydroxyphenyl) propionyloxymethyl)methane improved in coloring and production thereof
EP0808818B1 (en) * 1996-05-23 2000-09-20 Ciba SC Holding AG Process for the preparation of substituted hydroxy-hydrocinnamate esters
CA2574588A1 (en) 2004-07-23 2006-02-09 Polnox Corporation Anti-oxidant macromonomers and polymers and methods of making and using the same
CA2589855A1 (en) 2004-12-03 2006-06-08 Polnox Corporation Process for the synthesis of polyalkylphenol antioxidants
US7902317B2 (en) 2004-12-03 2011-03-08 Polnox Corporation Synthesis of aniline and phenol-based antioxidant macromonomers and corresponding polymers
WO2006091705A2 (en) 2005-02-22 2006-08-31 Polnox Corporation Nitrogen and hindered phenol containing dual functional macromolecular antioxidants: synthesis , performances and applications
WO2006104957A2 (en) 2005-03-25 2006-10-05 Polnox Corporation Alkylated and polymeric macromolecular antioxidants and methods of making and using the same
US20070149660A1 (en) 2005-10-27 2007-06-28 Vijayendra Kumar Stabilized polyolefin compositions
WO2007050985A2 (en) 2005-10-27 2007-05-03 Polnox Corporation Macromolecular antioxidants based on stξrically hindered phenolic phosphites
WO2007064843A1 (en) 2005-12-02 2007-06-07 Polnox Corporation Lubricant oil compositions
WO2008005358A2 (en) 2006-07-06 2008-01-10 Polnox Corporation Novel macromolecular antioxidants comprising differing antioxidant moieties: structures, methods of making and using the same
US7767853B2 (en) 2006-10-20 2010-08-03 Polnox Corporation Antioxidants and methods of making and using the same
WO2015077635A2 (en) 2013-11-22 2015-05-28 Polnox Corporation Macromolecular antioxidants based on dual type moiety per molecule: structures methods of making and using the same
WO2018160879A2 (en) 2017-03-01 2018-09-07 Polnox Corporation Macromolecular corrosion (mcin) inhibitors: structures, methods of making and using the same

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1081789A (en) * 1965-08-02 1967-08-31 Geigy Ag J R Transesterification process
GB1103145A (en) * 1964-06-02 1968-02-14 Geigy Ag J R Process for the preparation of organic esters
US3644482A (en) * 1961-10-30 1972-02-22 Geigy Ag J R (4-hydroxy-5-alkylphenyl) alkanoic acid esters of polyols
US3657322A (en) * 1967-06-26 1972-04-18 Ciba Geigy Corp Cycloaliphatic dialkylhydroxyphenylalkanoates
US3962313A (en) * 1973-12-06 1976-06-08 Martin Dexter Cycloaliphatic alkylhydroxyphenylalkanoates
US4405807A (en) * 1980-01-14 1983-09-20 Mitsui Petrochemical Industries, Ltd. Tetrakis[3-(3,5-di-t-butyl-4-hydroxyphenyl)propionyloxymethyl]methane having a novel crystal structure and process for production thereof
US4547585A (en) * 1981-05-28 1985-10-15 Mitsui Petrochemical Industries, Ltd. Process for preparing tetrakis [3-(3,5-dibutyl-4-hydroxyphenyl)propionyloxymethyl] methane
US4618700A (en) * 1983-12-22 1986-10-21 Ciba-Geigy Corporation Process for the preparation of a hydroxyphenylcarboxylate
EP0244361A2 (en) * 1986-04-30 1987-11-04 Ciba-Geigy Ag Individual beta-form crystals of tetrakis-[3-(3,5-di-t-butyl-4-hydroxyphenyl)-propionyloxymethyl] methane and process for their manufacture
US4885382A (en) * 1987-02-03 1989-12-05 Yoshitomi Pharmaceutical Industries, Ltd. Method of producing tetrakis[3,5-di-tert-butyl-4-hydroxyphenyl)propionyloxymethyl]methane
JPH02201846A (en) * 1988-12-31 1990-08-10 Samsung Electron Devices Co Ltd Plasma indication element and this driving method

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3644482A (en) * 1961-10-30 1972-02-22 Geigy Ag J R (4-hydroxy-5-alkylphenyl) alkanoic acid esters of polyols
GB1103145A (en) * 1964-06-02 1968-02-14 Geigy Ag J R Process for the preparation of organic esters
GB1081789A (en) * 1965-08-02 1967-08-31 Geigy Ag J R Transesterification process
US3657322A (en) * 1967-06-26 1972-04-18 Ciba Geigy Corp Cycloaliphatic dialkylhydroxyphenylalkanoates
US3962313A (en) * 1973-12-06 1976-06-08 Martin Dexter Cycloaliphatic alkylhydroxyphenylalkanoates
US4405807A (en) * 1980-01-14 1983-09-20 Mitsui Petrochemical Industries, Ltd. Tetrakis[3-(3,5-di-t-butyl-4-hydroxyphenyl)propionyloxymethyl]methane having a novel crystal structure and process for production thereof
US4547585A (en) * 1981-05-28 1985-10-15 Mitsui Petrochemical Industries, Ltd. Process for preparing tetrakis [3-(3,5-dibutyl-4-hydroxyphenyl)propionyloxymethyl] methane
US4618700A (en) * 1983-12-22 1986-10-21 Ciba-Geigy Corporation Process for the preparation of a hydroxyphenylcarboxylate
EP0244361A2 (en) * 1986-04-30 1987-11-04 Ciba-Geigy Ag Individual beta-form crystals of tetrakis-[3-(3,5-di-t-butyl-4-hydroxyphenyl)-propionyloxymethyl] methane and process for their manufacture
US4739102A (en) * 1986-04-30 1988-04-19 Ciba-Geigy Corporation Individual beta-form crystals of terakis-(3-(3,5-di-t-butyl-4-hydroxyphenyl)-propionyloxymethyl)-methane and process for its manufacture
US4885382A (en) * 1987-02-03 1989-12-05 Yoshitomi Pharmaceutical Industries, Ltd. Method of producing tetrakis[3,5-di-tert-butyl-4-hydroxyphenyl)propionyloxymethyl]methane
JPH02201846A (en) * 1988-12-31 1990-08-10 Samsung Electron Devices Co Ltd Plasma indication element and this driving method

Also Published As

Publication number Publication date
DE68911436T2 (en) 1994-06-09
EP0358157B1 (en) 1993-12-15
KR900004671A (en) 1990-04-12
DE68911436D1 (en) 1994-01-27
EP0358157A1 (en) 1990-03-14
KR920000911B1 (en) 1992-01-31

Similar Documents

Publication Publication Date Title
US5089655A (en) Individual α-form particle crystals of tetrakis[3-(3,5-di-t-butyl-4-hydroxyphenyl)propionyloxymethyl]methane and process for its production
US6022985A (en) Process for the preparation of 4-acetoxy-2α-benzoyloxy-5β, 20-epoxy-1, 7β-10β-trihydroxy-9-oxo-tax-11-en-13α-yl(2R,3S)-3-tert-b utoxy-carbonYlamino-2-hydroxy-3-phenylpropionate trihydrate
JP7220154B2 (en) Crystalline forms of amino lipids
JP2508949B2 (en) Crystal of N- (trans-4-isopropylcyclohexylcarbonyl) -D-phenylalanine and process for producing the same
US5463116A (en) Crystals of N- (trans-4-isopropylcyclohexlycarbonyl)-D-phenylalanine and methods for preparing them
EP3805195B1 (en) Crystal of 2,2&#39;-bis(carboxymethoxy)-1,1&#39;-binaphthyl
EP0244361B1 (en) Individual beta-form crystals of tetrakis-[3-(3,5-di-t-butyl-4-hydroxyphenyl)-propionyloxymethyl] methane and process for their manufacture
TWI787515B (en) Crystal substance of 2,2&#39;-bis (carboxymethoxy)-1,1&#39;-binaphthyl
JPH0272139A (en) Production of tetrakis(3-(3,5-di-t-butyl-4-hydroxyphenyl) propionyloxymethyl)methane having excellent powdery characteristics
JP2736265B2 (en) Method for producing α-crystal tetrakis [3- (3,5-di-tert-butyl-4-hydroxyphenyl) propionyloxymethyl] methane having excellent powder properties
JP3981520B2 (en) Method for separating organic compounds
US5117040A (en) Alpha crystals of tetrakis[3-(3,5-di-tert-butyl-4-hydroxyphenyl) propionyloxymethyl]methane which have good flowability and method of producing same
CN113801189A (en) Crystal form of factor D retarder and preparation method thereof
JPH07116105B2 (en) Independent particle α-crystal tetrakis [3- (3,5-di-t-butyl-4-hydroxyphenyl) propionyloxymethyl] methane and method for producing the same
EP0366808B1 (en) Method of crystallization and purification for obtaining stable crystalls of tetrakis 3-(3,5-di-tertiary-butyl-4-hydroxyphenyl)propionyloxymethyl- methane on an industrial scale
JPH06128195A (en) Production of tetrakis(3-@(3754/24)3,5-di-tertiary-butyl-4-hydroxyphenyl)propionyloxymethyl)methane
JPH0672960A (en) Production of granular beta-crystalline tetrakis(3-@(3754/24)3,5-di-t-butyl-4-hydroxyphenyl) propionyloxymethyl)methane
KR102466729B1 (en) Hexadecyl treprostinil crystals and methods for preparation thereof
US5705677A (en) Diphenyl oxalate-phenol adduct, process for producing the adduct and method of producing diphenyl oxalate from the adduct
US5124474A (en) Process for commerical-scale crystallization and purification of tetrakis[3-]methane for stably obtaining beta crystals thereof
JPH0249752A (en) Method for crystallizing and purifying beta-crystal of tetrakis(3-(3,5-di-tert-butyl-4-hydroxyphenyl)-propionyloxymethyl)methane
EP0583879A2 (en) Hydroxyphenylpropionic ester crystals and their production
JPH03271247A (en) Production of fumaric acid
JPH0515698B2 (en)
WO2024028273A1 (en) Novel crystalline forms of (s)-7-oxa-2-aza-spiro[4.5]decane-2-carboxylic acid [7-(3,6-dihydro-2h-pyran-4-yl)-4-methoxy-thiazolo[4,5-c]pyridin-2-yl]-amide and co-crystal forms thereof

Legal Events

Date Code Title Description
AS Assignment

Owner name: YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD., JAPAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNORS:MIURA, TAKANORI;KOHARA, MASANORI;OKA, KUNIHIDE;REEL/FRAME:005135/0053

Effective date: 19890830

FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

AS Assignment

Owner name: WELFIDE CORPORATION, JAPAN

Free format text: CHANGE OF NAME;ASSIGNOR:YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD.;REEL/FRAME:011347/0303

Effective date: 20000401

AS Assignment

Owner name: YOSHITOMI FINE CHEMICALS, LIMITED, JAPAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:WELFIDE CORPORATION;REEL/FRAME:012219/0605

Effective date: 20010911

AS Assignment

Owner name: API CORPORATION, JAPAN

Free format text: CHANGE OF NAME;ASSIGNOR:YOSHITOMI FINE CHEMICALS, LTD.;REEL/FRAME:013599/0084

Effective date: 20021001

REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
FP Lapsed due to failure to pay maintenance fee

Effective date: 20040218

STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362